OTC Markets OTCPK - Delayed Quote USD

Embla Medical hf. (OSSFF)

Compare

4.8067

0.0000

(0.00%)

At close: October 25 at 4:00 PM EDT

Currency in USD All numbers in thousands

Download

Breakdown

TTM

12/31/2023

12/31/2022

12/31/2021

12/31/2020

Total Revenue

840,305.0000

785,683.0000

718,650.0000

718,669.0000

629,503.0000

Cost of Revenue

319,173.0000

300,110.0000

278,902.0000

263,282.0000

238,268.0000

Gross Profit

521,132.0000

485,573.0000

439,748.0000

455,387.0000

391,235.0000

Operating Expense

416,002.0000

398,113.0000

372,609.0000

359,763.0000

337,969.0000

Operating Income

105,130.0000

87,460.0000

67,139.0000

95,624.0000

53,266.0000

Net Non Operating Interest Income Expense

-20,681.0000

-16,112.0000

-11,641.0000

-12,186.0000

-9,978.0000

Pretax Income

89,849.0000

76,007.0000

56,172.0000

86,640.0000

12,720.0000

Tax Provision

20,494.0000

17,206.0000

12,962.0000

20,984.0000

4,799.0000

Net Income Common Stockholders

69,066.0000

58,389.0000

42,513.0000

63,994.0000

6,214.0000

Diluted NI Available to Com Stockholders

69,066.0000

58,389.0000

42,513.0000

63,994.0000

6,214.0000

Basic EPS

0.16

0.14

0.10

0.16

0.01

Diluted EPS

0.16

0.14

0.10

0.15

0.01

Basic Average Shares

427,538.0790

420,297.0000

417,758.0000

422,161.0000

421,775.0000

Diluted Average Shares

427,559.0790

420,318.0000

417,831.0000

422,795.0000

422,725.0000

Total Operating Income as Reported

105,917.0000

89,387.0000

64,844.0000

97,311.0000

28,288.0000

Total Expenses

735,175.0000

698,223.0000

651,511.0000

623,045.0000

576,237.0000

Net Income from Continuing & Discontinued Operation

69,066.0000

58,389.0000

42,513.0000

63,994.0000

6,214.0000

Normalized Income

69,066.0000

58,389.0000

42,513.0000

63,994.0000

6,214.0000

Interest Income

2,181.0000

3,448.0000

779.0000

168.0000

459.0000

Interest Expense

21,261.0000

17,959.0000

11,204.0000

9,798.0000

9,611.0000

Net Interest Income

-20,681.0000

-16,112.0000

-11,641.0000

-12,186.0000

-9,978.0000

EBIT

111,110.0000

93,966.0000

67,376.0000

96,438.0000

22,331.0000

EBITDA

165,302.0000

143,886.0000

116,741.0000

147,966.0000

87,030.0000

Reconciled Cost of Revenue

319,173.0000

300,110.0000

278,902.0000

263,282.0000

238,268.0000

Reconciled Depreciation

54,192.0000

49,920.0000

49,365.0000

51,528.0000

64,699.0000

Net Income from Continuing Operation Net Minority Interest

69,066.0000

58,389.0000

42,513.0000

63,994.0000

6,214.0000

Normalized EBITDA

165,302.0000

143,886.0000

116,741.0000

147,966.0000

87,030.0000

Tax Rate for Calcs

0.0002

0.0004

12/31/2020 - 5/23/2019

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

EKTA-B.ST Elekta AB (publ)

68.75

-0.87%

REG1V.HE Revenio Group Oyj

31.86

-1.06%

XVIVO.ST Xvivo Perfusion AB (publ)

478.50

+0.74%

NXTMH.HE Nexstim Plc

5.24

-3.68%

SHL.DE Siemens Healthineers AG

51.32

-0.08%

CHEMM.CO ChemoMetec A/S

409.80

-1.59%

TLT.V Theralase Technologies Inc.

0.2900

-17.14%

AMBU-B.CO Ambu A/S

128.25

+0.39%

ESTA Establishment Labs Holdings Inc.

44.64

-0.51%

CLPT ClearPoint Neuro, Inc.

13.04

+3.66%

News

Life

Entertainment

Finance

Sports

New on Yahoo

Yahoo Finance

Embla Medical hf. (OSSFF)

Upgrade to begin using 40 years of financial statements and get so much more.

Related Tickers